Approach to a Patient with Adenomyosis FINAL
-
Upload
api-3700579 -
Category
Documents
-
view
482 -
download
0
Transcript of Approach to a Patient with Adenomyosis FINAL
![Page 1: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/1.jpg)
Gynecology Case Correlates
Barrera, Diana Jane
Atanga, Pascal
![Page 2: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/2.jpg)
E.E.
38 year-old housewife
Chief Complaint
Increased amount and duration of menses with menstrual pains
![Page 3: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/3.jpg)
History of Present Illness
27 months PTA • Increased in amount and duration of menses
– from 3 pads moderately soaked to 5 pads fully-soaked /day
– from 3 days to 7 days
• Accompanied by menstrual pain, grade 8/10, relieved by Mefenamic acid, 250 mg
• NO consultation.
![Page 4: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/4.jpg)
History of Present Illness
22 months PTA• There was persistence of above symptoms, not relieved by Mefenamic acid.
• Consulted a gynecologist (Dr. Jimenez?) at Westmin Hospital (Mindoro)– Abdominal and pelvic exam: unremarkable– TVS: “makapal na matres”– Advised hysterectomy; Patient did not
consent; lost to follow-up
Since then, self-medicated with Naproxen Sodium( Flanax) 550mg/tab which afforded relief of dysmenorrhea.
![Page 5: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/5.jpg)
History of Present Illness2 weeks PTA
Admission:
• Persistence of above symptoms– Further increased in amount of menses
• From 5 pads fully soaked (regular napkin) to 5 pads fully-soaked (maternity napkins)
• Progressive dysmenorrhea, grade 10/10, not relieved by Naproxen Sodium( Flanax)
550mg/tab• Consulted at OPD, USTH
– Abdominal/ pelvic exam: suprapubic tenderness on palpation, uterus enlarged to 2 1/2 m size
– Laboratory work-up: CBC– Transvaginal Ultrasound was done.
Results showed: Ultrasound
• Patient was admitted for hysterectomy.Admission
![Page 6: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/6.jpg)
Review of Systems• General: No significant weight changes. No fatigue or body
weakness. • Skin: No rashes or pigmentation. No pallor, generalized skin
scaliness, excessive sweating, or pruritus. No easy bruising.• HEENT: No history of head injury. No blurring of vision. No eye
redness or lacrimation. No hearing loss or tinnitus. No bleeding gums or sore throat.
• Neck: No lumps, goiter, pain. No swollen glands.• Respiratory: No cough. No hemoptysis. No wheezing.• Cardiovascular: No hypertension. • Gastrointestinal: No change of appetite. No occasional
vomiting. No hematemesis, dysphagia or indigestion. Regular bowel movements. No diarrhea or bleeding. No pain, jaundice, gallbladder or liver problems.
![Page 7: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/7.jpg)
Review of Systems
• Urinary: No oliguria. No frequency or urinary incontinence. No recent flank pain.
• Peripheral Vascular: No history of phlebitis or leg pain. • Musculoskeletal: No muscle pain. No joint stiffness and pain.• Psychiatric: No history of depression or treatment for psychiatric
disorders. • Neurologic: No seizures, fainting, motor or sensory loss. Has a
good memory.• Hematologic: No bleeding gums. No bruises. No history of
anemia.• Endocrine: No excessive sweating, heat or cold intolerance. No
polyuria, polydipsia or polyphagia;
![Page 8: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/8.jpg)
Personal ,Family and Social History
• Patient: Religion: Born AgainOccupation: fish vendor, house-wife– non-smoker– non-alcoholic drinker,– denied illicit drug use
Father : stroke, heart attack, and hypertension at 67.
![Page 9: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/9.jpg)
Past Medical History
• Childhood Illnesses: – Asthma; no other forms of allergy.
• Adult Illnesses: – Medical: UTI, 1996, treated. No bleeding problems.
• Psychiatric: None
![Page 10: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/10.jpg)
Obstetric/Gynecologic HistoryMenstruation history
• Menarche: 14 years old,• Interval: 28-29 days• Duration: 3 days• Amount : 3 pads/day, fully-soaked• Symptoms: no dysmenorrheal symptoms.
• LMP: February 12-18, 2009• PMP: January 10-14, 2009
Sexual History• first sexual contact: at 18• single partner, fisherman• No post coital bleeding or dyspareunia
![Page 11: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/11.jpg)
Obstetric/Gynecologic History
G5P4 (4016)• G1, January 1992, girl, 7lbs. term NSD, uncomplicated home delivery by
TBA.
• G2, August 1992, aborted at 3 months, dilatation and curettage was done (St. Joseph)
• G3, 1994, girl ,10 lbs. term,NSD, uncomplicated home delivery by TBA.
• G4, 1996,– caesarian section, triplets, 5.4, 5.7, 6.6 lbs. term– At St. Joseph’s Hospital.. – Pregnancy Complications: UTI, unknown medication, completely treated. – Gestational hypertension, unknown medication, well-managed.
• G5, 1999, boy, 6.0 lbs. term, NSD, uncomplicated home delivery by TBAFamily planning: none
![Page 12: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/12.jpg)
Physical examination
• General: conscious, coherent, ambulatory, not in cardio-respiratory distress
• Vital Signs: Height: 163 cm Weight: 63 kg BMI: 24
• BP: 110 60 supine, PR 80/min RR: 21 /min T-37.2 C
• Skin: Warm and smooth, no jaundice, no active dermatoses. Nails without clubbing or cyanosis
• HEENT: Pink palpebral conjunctiva, anicteric sclera
• No retained cerumen, no tragal tenderness, no hyperemic external auditory canal
• No nasal discharge, nasal septum midline
• Moist buccal mucosa, non-hyperemic posterior pharyngeal wall, tonsils not enlarged.
• Neck: Supple neck, no palpable cervical lymphadenopathy, thyroid not enlarged. Neck veins not distended.
![Page 13: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/13.jpg)
Physical examination• Thorax and Lungs: Symmetric chest, no chest wall deformities, no
retractions, no lagging, no tenderness, no palpable masses, equal tactile vocal fremiti, resonant on percussion, vesicular breath sounds, no crackles, no wheezes, no rhonchi.
• Cardiovascular: JVP 3 cm at 30 degrees. CAP, rapid upstroke, gradual downstroke, Negative for carotid bruit. Adynamic precordium, AB 5 th LICS AAL, no lifts, heaves or thrills, S1>S2 at apex, S2>S1 at the base. No murmurs.
• Breast: symmetrical, no skin lesions, no dimpling; non-tender on palpation, no palpable masses or lumps. No discharge.
• Abdominal: Flabby abdomen, with striae of pregnancy and vertical infraumbilical laparotomy scar; normoactive bowel sounds; with tenderness on low abdominal area on deep palpation; liver and spleen not palpable, no palpable intra-abdominal masses. tympanitic on percussion
![Page 14: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/14.jpg)
Physical examinationPelvic Exam: • On External inspection: • pubic hair triangular distribution; • no gross lesions of external genitalia• On Speculum Examination:• the cervix is smooth, long, firm and
closed with minimal whitish mucoid discharge.
• On internal Examination: • Uterus is symmetrically enlarged to
about 2 ½ month size,midline, movable, and anteverted, soft with slight tenderness on palpation.
• No adnexal masses• No nodularities in cul de sac.
![Page 15: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/15.jpg)
Physical examinationPelvic Exam: • On External inspection: • pubic hair triangular distribution; • no gross lesions of external genitalia• On Speculum Examination:• the cervix is smooth, long, firm and
closed with minimal whitish mucoid discharge.
• On internal Examination: • Uterus is symmetrically enlarged to
about 2 ½ month size,midline, movable, and anteverted, soft with slight tenderness on palpation.
• No adnexal masses• No nodularities in cul de sac.
![Page 16: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/16.jpg)
Salient Features• 38 years old, G5P4 (4016) with
multiple gestation
• Menorrhagia
• Progressive dysmenorrhea
• No drug use especially hormones, OCP’s
• Caesarian section• Dilatation and curettage
• No GIT and urinary symptoms
• No bleeding tendency/disorders
• Uterus symmetrically enlarged to 21/2 month size, midline and movable, soft, tender on palpation
• Tenderness on lower abdominal area in deep palpation.
• No signs and symptoms of anemia
![Page 17: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/17.jpg)
Secondary Dysmenorrhea with Menorrhagia
Differential Diagnosis
![Page 18: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/18.jpg)
table
Clinical Condition: ADENOMYOSIS ENDOMETRIOSIS LEIOMYOMA
Age of onset •Reproductive age group •30 and 50 •Median age 40 years
•Reproductive age group•Earlier, 20-40
•Reproductive age group
Characteristic of pain
•Cyclic•usually premenstrual and menstrual
•Cyclic•usually premenstrual and menstrual
•Mostly asymptomatic
Signs •Uterus is diffusely enlarged, •<14 cm in size,•Soft and tender, at the time of menses. •Mobility not restricted, •No associated adnexal pathology•Direct tenderness
•Uterus not enlarged•Retro-verted uterus with•tender nodules in the uterosacral region or thickening of the cul-de-sac•No rebound tenderness Adhesions are common
•Enlargement of uterus is asymmetric, pelvic mass•May occur singly but often are multiple.
Symptoms •Excessively heavy or prolonged menstrual bleeding, •dysmenorrhea
•Abnormal bleeding tends to be premenstrual spotting •dysmenorrhea•Associated GI symptoms
•Abnormal bleeding, pelvic pressure•BUT •Usually asymtomatic
Risk Factors •Multiparity•Cesarean sections•D and C•tubal ligations
•Never given birth•Endometriosis in mother•menstrual cycles < 27 days• bleeding > 8 days•normal passage of menses.•the pelvis by previous•Being white or Asian
•Obese women•Diet•exercise
![Page 19: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/19.jpg)
Impression
Given a patient who is
of the reproductive age group …
with regular menstrual cycle…
presenting with menorrhagia and secondary dysmenorrhea…
and a symmetrically enlarged uterus…
ADENOMYOSIS
![Page 20: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/20.jpg)
ADENOMYOSIS
• a condition where endometrial glands and supporting tissues are found in the muscular wall of the uterus
![Page 21: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/21.jpg)
Adenomyosis• The reported prevalence of adenomyosis in the literature
ranges from 20% to 30%• This condition typically affects women in the fourth and fifth
decades of life. • Menorrhagia and dysmenorrhea have been reported to
occur in 40% to 50% and 15% to 30% of patients, respectively,
• approximately one-third being asymptomatic. • Metrorrhagia, nonmenstrual pelvic pain, and dyspareunia
may also be present.•
Azziz R. Adenomyosis: current perspectives. Obstet Gynecol Clin North Am 1989;16:221–235.
![Page 22: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/22.jpg)
Adenomyosis• The diagnosis is made histopathologically • Endometrial stroma and glands are observed at least 2 to 3 mm
below the endometrial surface within the myometrium. • The cause of the pain associated with this condition is not known. • Ultrasonography and hysterosalpingography are not useful in the
diagnosis of adenomyosis. • However, magnetic resonance imaging (MRI) can be used to
diagnose adenomyosis. • Hysterectomy has consistently been shown to be successful in
treating and controlling the symptoms associated with adenomyosis.
Azziz R. Adenomyosis: current perspectives. Obstet Gynecol Clin North Am 1989;16:221–235.
![Page 23: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/23.jpg)
ADENOMYOSIS
Incidence
- 20.6 % of the specimen studied
- total of 296 hysterectomy specimen (dysfunctional uterine bleeding)
Incidence of adenomyosis in hysterectomies. Anwar Ali. Department of Pathology, Saidu Medical College, Swat.Pakistan J. Med. Res.Vol. 44 No.1, 2005
![Page 24: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/24.jpg)
ADENOMYOSISRisk factors
“Women who smoked tended to be at decreased risk of the
condition: in comparison with women who had never smoked, the risk for
current smokers was 0.7 (0.3- 1.3)”
“The frequency of adenomyosis was higher in parous women: in comparison with nulliparae, the odds ratio of the disease were 1.8 [95% confidence interval (CI) 0.9-3.4] and 3.1 (95% CI 1.7-5.5) respectively in women reporting one and two or more births (chi2 trend 20.71, P < 0.01).”
“ ..women reporting one or more spontaneous abortions had an odds ratio of 1.7 (95% CI 1.1-2.6) for adenomyosis, in comparison with those reporting no spontaneous abortion.
Risk factors for adenomyosis. F Parazzini, P Vercellini, S Panazza, L Chatenoud, S Oldani and PG Crosignani Centro Medicina della
Riproduzione,Clinica Ostetrico Ginecologica Universita di Milano, Italy.
• Others: uterine surgery
![Page 25: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/25.jpg)
• CBC
• Transvaginal Ultrasound
Work-ups
![Page 26: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/26.jpg)
Transvaginal Ultrasound
Why do we request ?
• confirm the cause of enlarged uterus• location and extent of lesion• assessment of endometrial lining• assess the ovaries
![Page 27: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/27.jpg)
The subendometrial halos a thin hypoechoic band (arrows).
The endometrium is uniformly echogenic
NORMAL
Transvaginal Ultrasound
![Page 28: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/28.jpg)
6-8cm 3-5 cm
![Page 29: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/29.jpg)
7-14mm
![Page 30: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/30.jpg)
ADENOMYOSIS characteristics
• Heterogeneous myometrial echotexture
• Ill defined hypoechoic areas
• Small anechioc lakes
• Symmetrical uterine enlargement
• Indistinct endometrial-myometrial border
• Posterior wall involvement
Transvaginal Ultrasound
![Page 31: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/31.jpg)
![Page 32: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/32.jpg)
Uterine dimensions
Symmetry of myometrium
Echogenicity of the myometrium
Brosens and co-workers assessed ultrasonographic details of adenomyosis such as:
They found that the most predictive is the ill-defined heterogeneous echotexture within the myometrium.
Transvaginal Ultrasound
![Page 33: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/33.jpg)
![Page 34: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/34.jpg)
![Page 35: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/35.jpg)
BACK
pix
![Page 36: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/36.jpg)
Work-Up Results: TVSCervix: 4.12 x 3.9 cmUterine Corpus: 8.64 x 8.85 x 8.26 cm*
AntevertedInhomogenous
Endometrium: 0.84 cmIsoechoic
Ovaries Right: 2.75 x 1 x 1.94 cm
Follicles: <10 mmLeft: 2.59 x 2.06 x 2.4 cm
Follicles < 10 mmOther Findings: Cul-de-sac: Minimal fluid
*Coarse area noted at the anterior wall – 4.42 x4.03 cm (adenomyosis)*Hypoechoic nodule noted at the lower anterior wall – 1.33 x 1.03 x 1.14 cm
REMARKS:ENLARGED UTERUS WITH ADENOMYOSIS AND INTRAMURAL MYOMAPROLIFERATVE ENDOMETRIUMNORMAL – SIZED OVARIES
![Page 37: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/37.jpg)
Ultrasound Correlations
![Page 38: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/38.jpg)
Management
• Surgical
Abdominal Hysterectomy– Age, no desire for child-bearing anymore– Definitive treatment
• Medical
- if young and desire for child bearing
- poor surgical risk, with co morbidities, etc
- hormones are mainstay of medical treatment
- not definitive, signs and symptoms recur upon withdrawal
![Page 39: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/39.jpg)
Management
Problems
Adenomyosis
- Menorrhagia and secondary dysmenorrhea
Anemia
Goals
• Definitive removal of the lesion and relieve of symptoms
• Correction of anemia (prior to operation)
![Page 40: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/40.jpg)
Management
TOTAL ABDOMINAL HYSTERECTOMY
![Page 41: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/41.jpg)
PREOPERATIVE • Informed consent• Laboratory: CBC, BT, Blood typing and cross-matching ,RBS• Kidney function test – urinalysis, BUN, Creatinine• Liver Function Test - TPAG• Chest X-ray • ECG – cardio-pulmonary clearance• Correct ANEMIA• Bowel preparation (simple hysterectomy)
- Light dinner, NP0 (8 hours)– Cleansing enema
• Prophylactic antibiotics (first gen. cephalosporin)• IV fluids
Management
![Page 42: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/42.jpg)
Intraoperative
![Page 43: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/43.jpg)
![Page 44: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/44.jpg)
![Page 45: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/45.jpg)
back
![Page 46: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/46.jpg)
![Page 47: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/47.jpg)
![Page 48: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/48.jpg)
Management
Post-operative• Vital signs monitoring• IV fluids• NPO to clear to soft diet• Analgesics• Prevent complications
– Pneumonia– DVT– Bedsores– SSI
![Page 49: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/49.jpg)
The diagnosis can only be proven by the pathologists
But a good gynecologist may suspect adenomyosis based on the clinical factors, but
the final diagnosis usually has to wait until hysterectomy is performed
![Page 50: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/50.jpg)
THANK YOU
![Page 51: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/51.jpg)
BACK UP SLIDES
![Page 52: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/52.jpg)
Work-Up Results: CBC
BACK
![Page 53: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/53.jpg)
Work-Up Results: TVSCervix: 4.12 x 3.9 cmUterine Corpus: 8.64 x 8.85 x 8.26 cm*
AntevertedInhomogenous
Endometrium: 0.84 cmIsoechoic
Ovaries Right: 2.75 x 1 x 1.94 cm
Follicles: <10 mmLeft: 2.59 x 2.06 x 2.4 cm
Follicles < 10 mmOther Findings: Cul-de-sac: Minimal fluid
*Coarse area noted at the anterior wall – 4.42 x4.03 cm (adenomyosis)*Hypoechoic nodule noted at the lower anterior wall – 1.33 x 1.03 x 1.14 cm
REMARKS:ENLARGED UTERUS WITH ADENOMYOSIS AND INTRAMURAL MYOMAPROLIFERATVE ENDOMETRIUMNORMAL – SIZED OVARIES
![Page 54: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/54.jpg)
Medical Management: Medical
• GnRH- agonists is efficient in reducing the adenomyotic uterine size.
• GnRH-alpha treatment before laparoscopic surgery greatly decreases surgical difficulties and blood loss in certain cases.
Gonadotropin releasing hormone agonists in the treatment of adenomyosis. Obstetricts and Gynecology Hospital, Shanghai Medical University, Shanghai 200011
Zhonghua Fu Chan Ke Za Zhi 1999 Apr; 34:214-6 BACK
![Page 55: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/55.jpg)
Management: Uterine Artery Embolization
UAE procedures were performed in 23 patients with adenomyosis. After treatment the symptoms and uterine volume of all patients were investigated.
All clinical symptoms of 23 patients relieved.
•Dysmenorrhea completely disappeared in 19 patients, significantly alleviated in 2 patients. But in other 2 recurred.
•The uterine volume shrunk significantly [(50 +/- 18)%] vs [(100 +/- 0)%].
•The blood flow within the uterine and lesions detect by color doppler flow imaging decreased immediately after UAE.
•Low-abdominal pain and slight fever were seen after treatment and recovered within 1 - 2 weeks.
Uterine arterial embolization in the treatment of adenomyosis .Chen C, Liu P, Lu J, Yu L, Ma B, Wang J, Liu PZhonghua Fu Chan Ke Za Zhi 2002 Feb.
![Page 56: Approach to a Patient with Adenomyosis FINAL](https://reader031.fdocuments.us/reader031/viewer/2022020207/553e6a945503466f328b49e5/html5/thumbnails/56.jpg)
UAE is an effective and safe method in the treatment of
adenomyosis.
BUT the recurrence rate is not yet evaluated.
Management: Uterine Artery Embolization